Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1966 1
1967 1
1968 1
1969 4
1970 3
1971 8
1972 4
1973 1
1974 2
1975 2
1976 5
1977 1
1978 6
1979 5
1980 1
1981 2
1982 3
1983 3
1986 4
1987 6
1988 4
1989 8
1990 5
1991 4
1992 5
1993 1
1994 5
1995 1
1996 5
1997 7
1998 4
1999 6
2000 10
2001 3
2002 7
2003 3
2004 6
2005 8
2006 13
2007 15
2008 11
2009 14
2010 20
2011 9
2012 7
2013 11
2014 10
2015 7
2016 7
2017 7
2018 18
2019 8
2020 8
2021 17
2022 26
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Usefulness of Combined Measurement of Surfactant Protein D, Thrombin-Antithrombin III Complex, D-Dimer, and Plasmin-α2 Plasmin Inhibitor Complex in Acute Exacerbation of Interstitial Lung Disease: A Retrospective Cohort Study.
Takeshita Y, To M, Kurosawa Y, Furusho N, Kinouchi T, Tsushima K, Tada Y, To Y, Sakao S. Takeshita Y, et al. Among authors: tsushima k. J Clin Med. 2024 Apr 21;13(8):2427. doi: 10.3390/jcm13082427. J Clin Med. 2024. PMID: 38673700 Free PMC article.
Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases.
Sun Y, Saito K, Ushiki A, Abe M, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Takemoto K, Ishikawa R, Momiyama T, Matsuyama SI, Arakawa N, Akane H, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Sun Y, et al. Among authors: tsushima k. Respir Res. 2024 Jan 14;25(1):31. doi: 10.1186/s12931-023-02653-6. Respir Res. 2024. PMID: 38221627 Free PMC article.
Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Shimasaki S, Baba T, Ogura T, Akasaka K, Matsushima H, Izumi S, Takasaki J, Tsushima K, Kinouchi T, Kichikawa Y, Awashima M, Izumo T, Awano N, Nishimura N, Tazawa R, Mikami A, Kitamura N, Ishii H, Kurihara Y, Taniguchi M, Aikawa S, Okada M, Morita Y, Ishikawa Y, Ohinata A, Nakata K. Shimasaki S, et al. Among authors: tsushima k. Infect Dis (Lond). 2023 Dec;55(12):857-873. doi: 10.1080/23744235.2023.2254380. Epub 2023 Oct 6. Infect Dis (Lond). 2023. PMID: 37729076 Clinical Trial.
Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan.
Umeda A, Shimada H, Yamane T, Mochizuki T, Inoue Y, Tsushima K, Miyagawa K, Mochida A, Takeda H, Okada Y, Masaki K, Matsusaka M, Fukunaga K. Umeda A, et al. Among authors: tsushima k. Front Physiol. 2023 Apr 21;14:1131949. doi: 10.3389/fphys.2023.1131949. eCollection 2023. Front Physiol. 2023. PMID: 37179838 Free PMC article.
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan.
Hirasawa Y, Terada J, Shionoya Y, Fujikawa A, Isaka Y, Takeshita Y, Kinouchi T, Koshikawa K, Tajima H, Kinoshita T, Tada Y, Tatsumi K, Tsushima K. Hirasawa Y, et al. Among authors: tsushima k. Respir Investig. 2023 Jul;61(4):438-444. doi: 10.1016/j.resinv.2023.03.009. Epub 2023 Apr 18. Respir Investig. 2023. PMID: 37119744 Free PMC article.
355 results